Portside Wealth Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$397K	Sell	3,493 -82	-2%	-$9.32K	0.06%	283
2025 Q1	$376K	Buy	3,575 +112	+3%	+$11.8K	0.06%	278
2024 Q4	$371K	Buy	3,463 +363	+12%	+$38.9K	0.06%	274
2024 Q3	$310K	Buy	3,100 +378	+14%	+$37.8K	0.05%	302
2024 Q2	$229K	Buy	+2,722	New	+$229K	0.04%	318